Cancer Information Highlights, August 28, 2019

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI MGUS to Myeloma: Study Suggests Risk of Progression Can Change   Read about a new study that suggests a person's risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma can change over time. Newly Discovered Protein May Be Immunotherapy Target Scientists have discovered an immune checkpoint protein that may be a new target for immunotherapy. Learn about this protein and the types of cancers that might be targeted by blocking it. Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases An NCI-funded clinical trial is testing the immunotherapy drug nivolumab (Opdivo) in people who have advanced cancer and an autoimmune disease, such as rheumatoid arthritis, lupus, or multiple sclerosis, who are often excluded from such trials. Sentinel Lymph Node Biopsy Review this updated page to learn about sentinel lymph node biopsy, including why it is used, when it is used, and the benefits and harms of the procedure. PDQ Cancer Information Summary Updates New Patient Summary on Hereditary Syndromes Associated with Kidney Cancer In this new PDQ summary, learn who might benefit from genetic counseling and testing for kidney cancer and about the four known hereditary kidney cancer syndromes and the genes that cause them. It also has new medical drawings to explain autosomal inheritance and show areas of the body affected by the different syndromes. Drug Information Updates New Drug Approved for Prostate Cancer We've added a new drug information summary on darolutamide (Nubeqa), which was recently approved by the Food and Drug Administration to treat metastatic prostate cancer that is castration resistant.   Also of Interest Stopping Multiple Myeloma in Its Tracks When Valerie Winston was diagnosed with smoldering myeloma, she was not comfortable with the standard watch-and-wait approach and decided to join a clinical trial. Read more about her story. Help Finding NCI-Supported Clinical Trials This page explains how to use the basic and advanced clinical trials search forms to find NCI-supported clinical trials, how to understand the trials that you find, and ways to get more help.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892